The partnership, which began in 2017, focuses on synchronizing ACTO’s AI-powered learning and roleplay capabilities with Veeva’s core enterprise systems, including Vault CRM, PromoMats, and MedComms. By achieving Gold status, ACTO gains formal recognition for its validated integrations that allow field representatives and medical science liaisons to access approved messaging and real-time intelligence without leaving their primary workflows.
ACTO Reaches Veeva Gold Partner Status After Decade of Integration
After nearly ten years of collaboration, Toronto-based ACTO has secured Veeva Gold Product Partner status. The designation underscores the company's progress in embedding AI-driven field excellence tools directly into the foundational platforms used by pharmaceutical and biotech sales teams to manage content and customer interactions.
Parth Khanna, CEO of ACTO, noted that the integration helps field teams maintain precision during rapid scientific updates or new product launches. The platform leverages CxZone for AI-simulated roleplay and ACTO Talk TRx to provide practitioners with immediate, compliant talking points during healthcare professional exchanges. Kristn Peck, Vice President of Alliances at Veeva, cited the company’s sustained investment in validated solutions as the primary driver for this new tier of partnership. ACTO currently serves 14 of the top 50 pharmaceutical companies, providing tools designed to navigate complex regulatory requirements while automating routine field tasks.
Comments (0)
No comments yet. Be the first!